CinCor Pharma, Inc.
Related Filers (45)
- Allison David D. (6)
- Pearce Catherine (6)
- 5AM Ventures VI, L.P. (5)
- GENERAL ATLANTIC, L.P. (5)
- Sofinnova Venture Partners X, L.P. (5)
- HEALY JAMES (4)
- Sofinnova Capital IX (4)
- CinRx Pharma, LLC (3)
- 5AM Partners VI, LLC (3)
- 5AM Opportunities I, L.P. (3)
- 5AM Opportunities I (GP), LLC (3)
- Schwab Andrew J. (3)
- General Atlantic (CIN), L.P. (3)
- GAP Coinvestments V, LLC (3)
- Sofinnova Management X, L.L.C. (3)
- General Atlantic Partners (Bermuda) EU, L.P. (3)
- GAP COINVESTMENTS IV, LLC (3)
- GENERAL ATLANTIC GENPAR, L.P. (3)
- Katabi Maha (3)
- General Atlantic Partners (Lux), SCSp (3)
- General Atlantic (Lux) S.a r.l. (3)
- GAP (Bermuda) L.P. (3)
- GENERAL ATLANTIC GENPAR (BERMUDA), L.P. (3)
- General Atlantic Partners 100, L.P. (3)
- General Atlantic (SPV) GP, LLC (3)
- General Atlantic GenPar (Lux) SCSp (3)
- GAP COINVESTMENTS III, LLC (3)
- GAP Coinvestments CDA, L.P. (3)
- Sofinnova Partners SAS (3)
- PARMAR KUSH (3)
- Freeman Mason (3)
- Kalb Michael Wayne (3)
- de Garidel Marc (3)
- ASTRAZENECA PLC (3)
- Lee June (2)
- Coelho Mary Theresa (2)
- venBio Global Strategic Fund III, L.P. (2)
- ADAGE CAPITAL PARTNERS GP, L.L.C. (2)
- Bhaman Maina (1)
- Ignelzi Troy A. (1)
- Pitts Jason (1)
- THERO JOHN F (1)
- 5AM Opportunities II (GP), LLC (1)
- 5AM Opportunities II, L.P. (1)
- PERCEPTIVE ADVISORS LLC (1)
- Show More ...
Financials (4)
10-Q
Thursday, 11/3/2022
Quarterly Report for period ending 2022-09-30
10-Q
Monday, 8/8/2022
Quarterly Report for period ending 2022-06-30
10-Q
Tuesday, 5/10/2022
Quarterly Report for period ending 2022-03-31
10-K
Tuesday, 3/22/2022
Annual Report for period ending 2021-12-31
News (13)
8-K
Monday, 1/9/2023
Current report filing
8-K
Monday, 11/28/2022
Current report filing
8-K
Tuesday, 11/8/2022
Current report filing
8-K
Monday, 11/7/2022
Current report filing
8-K/A
Friday, 11/4/2022
Current report filing
8-K
Thursday, 11/3/2022
Current report filing
8-K
Thursday, 8/11/2022
Current report filing
8-K
Monday, 8/8/2022
Current report filing
8-K
Monday, 8/8/2022
Current report filing
8-K
Tuesday, 5/10/2022
Current report filing
8-K
Tuesday, 3/22/2022
Current report filing
8-K
Friday, 1/28/2022
Current report filing
8-K
Tuesday, 1/11/2022
Current report filing
Other (17)
SC 14D9/A
Wednesday, 2/15/2023
Tender offer solicitation/recommendation statements filed under Rule 14d-9
SC 14D9/A
Monday, 2/13/2023
Tender offer solicitation/recommendation statements filed under Rule 14d-9
SC 14D9/A
Friday, 2/3/2023
Tender offer solicitation/recommendation statements filed under Rule 14d-9
SC 14D9
Monday, 1/23/2023
Tender offer solicitation/recommendation statements filed under Rule 14d-9
SC14D9C
Monday, 1/9/2023
Written communication by the subject company relating to a third party tender offer
POS EX
Thursday, 8/11/2022
Post-effective amendment filed solely to add exhibits to a registration statement
EFFECT
Wednesday, 8/10/2022
Notice of Effectiveness
CORRESP
Monday, 8/8/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 8/8/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Friday, 1/7/2022
None
EFFECT
Thursday, 1/6/2022
Notice of Effectiveness
CERT
Wednesday, 1/5/2022
Certification by an exchange approving securities for listing
CORRESP
Tuesday, 1/4/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 1/4/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
8-A12B
Tuesday, 1/4/2022
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
SEC STAFF LETTER
Tuesday, 12/21/2021
None
D
Tuesday, 10/12/2021
Exempt (Private) Offering
Ownership (63)
SC 13G
Tuesday, 2/14/2023
PERCEPTIVE ADVISORS LLC: Major Shareholders
SC 13D
Monday, 2/13/2023
Sofinnova Capital IX: Major Shareholders
SC 13G/A
Thursday, 2/9/2023
ADAGE CAPITAL PARTNERS GP, L.L.C.: Major Shareholders
4
Monday, 1/30/2023
de Garidel Marc: Statement of changes in beneficial ownership of securities
4
Monday, 1/30/2023
Pearce Catherine: Statement of changes in beneficial ownership of securities
4
Monday, 1/30/2023
Kalb Michael Wayne: Statement of changes in beneficial ownership of securities
4
Monday, 1/30/2023
Freeman Mason: Statement of changes in beneficial ownership of securities
4
Thursday, 1/19/2023
Pearce Catherine: Statement of changes in beneficial ownership of securities
SC 13D
Wednesday, 1/18/2023
5AM Ventures VI, L.P.: Major Shareholders
SC 13D/A
Wednesday, 1/11/2023
GENERAL ATLANTIC, L.P.: Major Shareholders
4
Tuesday, 1/10/2023
Allison David D.: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/8/2022
Kalb Michael Wayne: Initial statement of beneficial ownership of securities
4
Tuesday, 11/8/2022
Kalb Michael Wayne: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/12/2022
Allison David D.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 9/26/2022
venBio Global Strategic Fund III, L.P.: Major Shareholders
SC 13D/A
Monday, 8/22/2022
Sofinnova Venture Partners X, L.P.: Major Shareholders
4
Wednesday, 8/17/2022
Sofinnova Partners SAS: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/17/2022
Schwab Andrew J.: Statement of changes in beneficial ownership of securities
4
Monday, 8/15/2022
GENERAL ATLANTIC, L.P.: Statement of changes in beneficial ownership of securities
4
Monday, 8/15/2022
Sofinnova Management X, L.L.C.: Statement of changes in beneficial ownership of securities
4
Monday, 8/15/2022
HEALY JAMES: Statement of changes in beneficial ownership of securities
4
Monday, 8/15/2022
GAP Coinvestments CDA, L.P.: Statement of changes in beneficial ownership of securities
4
Monday, 8/8/2022
HEALY JAMES: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/20/2022
Allison David D.: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 7/20/2022
Allison David D.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/11/2022
Allison David D.: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 1/21/2022
GENERAL ATLANTIC, L.P.: Major Shareholders
SC 13G
Friday, 1/21/2022
ADAGE CAPITAL PARTNERS GP, L.L.C.: Major Shareholders
SC 13G
Friday, 1/21/2022
5AM Ventures VI, L.P.: Major Shareholders
SC 13D
Friday, 1/21/2022
Sofinnova Venture Partners X, L.P.: Major Shareholders
4
Thursday, 1/13/2022
GENERAL ATLANTIC, L.P.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
Coelho Mary Theresa: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
GAP Coinvestments CDA, L.P.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
Freeman Mason: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
Sofinnova Management X, L.L.C.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
de Garidel Marc: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
HEALY JAMES: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
Sofinnova Partners SAS: Statement of changes in beneficial ownership of securities
4/A
Thursday, 1/13/2022
Pearce Catherine: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
CinRx Pharma, LLC: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
Pearce Catherine: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
Schwab Andrew J.: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 1/11/2022
CinRx Pharma, LLC: Major Shareholders
SC 13G
Tuesday, 1/11/2022
venBio Global Strategic Fund III, L.P.: Major Shareholders
4
Monday, 1/10/2022
Lee June: Statement of changes in beneficial ownership of securities
4
Monday, 1/10/2022
Pearce Catherine: Statement of changes in beneficial ownership of securities
3
Monday, 1/10/2022
CinRx Pharma, LLC: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
Sofinnova Management X, L.L.C.: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
Ignelzi Troy A.: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
Pearce Catherine: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
Lee June: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
Bhaman Maina: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
Sofinnova Partners SAS: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
Coelho Mary Theresa: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
de Garidel Marc: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
Allison David D.: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
Freeman Mason: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
GENERAL ATLANTIC, L.P.: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
HEALY JAMES: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
Schwab Andrew J.: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
Pitts Jason: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
THERO JOHN F: Initial statement of beneficial ownership of securities
3
Thursday, 1/6/2022
GAP COINVESTMENTS III, LLC: Initial statement of beneficial ownership of securities
Prospectus (18)
SC TO-T/A
Friday, 2/3/2023
Third party tender offer statement
SC TO-T
Monday, 1/23/2023
Third party tender offer statement
SC TO-C
Monday, 1/9/2023
Written communication relating to an issuer or third party tender offer
424B4
Friday, 8/12/2022
Prospectus filed pursuant to Rule 424(b)(4)
S-1MEF
Wednesday, 8/10/2022
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1
Monday, 8/8/2022
General form of registration statement for all companies including face-amount certificate companies
DRS
Monday, 7/25/2022
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
S-8
Wednesday, 1/12/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Friday, 1/7/2022
Prospectus filed pursuant to Rule 424(b)(4)
S-1MEF
Thursday, 1/6/2022
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1/A
Monday, 1/3/2022
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Thursday, 12/23/2021
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 12/17/2021
General form of registration statement for all companies including face-amount certificate companies
DRS/A
Wednesday, 12/1/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Tuesday, 11/30/2021
Correspondence Related to Draft Registration Statement
DRS/A
Thursday, 10/14/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Wednesday, 10/13/2021
Correspondence Related to Draft Registration Statement
DRS
Friday, 8/27/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy